Scientists unveiled an intelligent design framework for adeno‑associated virus (AAV) vectors that dynamically respond to tumor microenvironment cues to improve tumor targeting and intratumoral delivery. The study details modular elements that sense local signals and alter tropism or payload expression within the TME, addressing longstanding delivery barriers for viral gene therapies. Developers say the approach could raise the therapeutic index for oncolytic and gene‑replacement strategies.